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Abstract
Epidermolysis Bullosa (EB) is a group of rare genetic disorders resulting in skin fragility and other symptoms.
Commissioned by DEBRA International and funded by DEBRA Norway, this evidence-bases guideline provides
recommendations to optimise psychosocial wellbeing in EB.
An international multidisciplinary panel of social and health care professionals (HCP) and people living with EB was
formed. A systematic international literature review was conducted by the panel following the Scottish Intercollegiate
Guidelines Network (SIGN) methodology. The resulting papers underwent systematic selection and critique processes.
Included papers were allocated to 6 different outcome groups to allow data synthesis and exploration: quality of life,
coping, family, wellbeing, access to HCP and pain. Based on the evidence in those papers, recommendations were made
for individuals living with EB, family and caregivers and HCP working in the field.
Few studies have investigated interventions and which factors lead to better outcomes, but general recommendations
can be made. EB is a complex disease impacting enormously on every aspect of psychosocial life. People and families
living with EB need access to multidisciplinary support, including psychological guidance, in order to improve quality of
life and psychosocial wellbeing. Interventions should stimulate social participation to prevent isolation. People with EB
and their families should be able to access a supportive network. HCP should be well supported and educated about the
complexity of EB. They should work collaboratively with those around the individual with EB (e.g. schools, employers etc.)
to provide psychosocial opportunity and care.
Attention should be paid to the psychosocial impact of EB as well as physical needs. Directions for research are indicated.
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Introduction
Epidermolysis Bullosa (EB) is a group of rare genetic dis-
orders, the primary manifestation is the formation of
blisters and erosions in response to mechanical trauma
[1]. While there are currently over 30 known subtypes of
EB, there are four primary types including EB Simplex
(EBS), Dystrophic EB (DEB), Junctional EB (JEB), and
Kindler syndrome (KS) [1, 2]. EB can be the result of
either inherited or spontaneous dominant mutations, as
seen in most forms of EBS and Dominant DEB (DDEB);
or from inherited recessive mutations as in rare forms of
EBS, Recessive DEB (RDEB), JEB, and KS [2].
The severity and scope of EB varies widely by type and
subtype. The mildest forms of EBS and DDEB may be lim-
ited to localised bullae (blisters) and wounds which can be
very painful, impacting quality of life (QoL) [1]. More se-
vere forms of EBS, RDEB, and JEB can result in general-
ised bullae and erosions, with significant extracutaneous
involvement, which may require the care of a large multi-
disciplinary team. Potential complications of more severe
EB include, but are not limited to, sepsis, anaemia, failure
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to thrive, pseudosyndactyly, contractures, and squamous
cell carcinoma [3–12]. Average life expectancy for those
with severe RDEB is about 30 years of age [13]. With the
exception of infant mortality, seen in rare cases of EBS,
and more commonly in JEB, life expectancy is thought to
be unaffected in other forms of EB [4, 6].
Currently there is no cure for EB; all known treat-
ments at this point are experimental. The mainstay of
EB management continues to be supportive in nature,
with symptom control and wound care at the centre.
Wound care can be a very painful and lengthy process,
lasting up to several hours a session, done daily or every
other day for most patients [14]. As a result of the time
it takes to care for the medical needs and the pain and
discomfort that is inherent with the condition, EB can
significantly impact all domains of a patient and family’s
life. This includes interactions with family, friends, and
peers, education, employment and leisure time [15–17].
Due to the profound impact of EB, it is understandable
that many individuals living with EB may struggle with
physiological suffering and psychosocial sequelae.
Psychosocial health is a broad term defined by the
American Psychological Association as ‘describing the
intersection and interaction of social, cultural and envir-
onmental influences on the mind and behaviour’ [18].
Whilst some individuals will be able to successfully navi-
gate their lives without psychosocial intervention or as-
sistance from the health care team, many would likely
benefit from assessment and intervention. Unfortunately,
at this time, there is little in the way of guidance for cli-
nicians regarding how to best care for the psychosocial
health of patients and families affected by EB. When we
consider the extent to which their lives can be affected,
and the impact that psychosocial health can have on
one’s physical health, this is a pressing need for those in
the EB community.
DEBRA International (DI) therefore sponsored the de-
velopment of psychosocial clinical practice guidelines
(CPGs) for individuals and families living with EB. In 2016
an expert panel was convened by DI comprising clinicians
from several countries with expertise related to social care
and mental health and EB, people living with EB and fam-
ily members from the international EB community.
An extensive systematic literature search and synthesis
was conducted by the expert panel. Based on the synthesis
of the literature and priorities raised by the EB commu-
nity, six outcomes were found to be relevant with regards
to the psychosocial health of those affected by EB: QoL,
coping, family, well-being, access to health care profes-
sionals (HCPs) and pain. Whilst the concepts of QoL,
coping and well-being are complex with many interpreta-
tions and some overlap, the expert panel agreed on the
following published definitions for each of these three
concepts:
❖ QoL: defined as an ‘individual’s perception of their
position in life, in the context of the culture and value
systems in which they live and in relation to their
goals, expectations, standards and concerns. It is a
broad ranging concept affected in a complex way by
the person’s physical health, psychological state, level
of independence, social relationships, personal beliefs
and their relationship to salient features of their
environment’ [19].
❖ Coping: defined as ‘thoughts and behaviours that
people use to respond to internal or external stressful
demands’ [20].
❖ Well-being: defined as the ‘balance point between an
individual’s resource pool and the challenges faced’ [21].
An evidence-based discussion of the impact of EB on
QoL, coping, family, well-being, access to HCPs and
pain follows. The synthesis and discussion include sug-
gestions for potential prevention, intervention strategies
and suggestions for future research.
Objectives of the CPG
❖ Provide guidance on the psychosocial needs of people
with EB, their families and those who care for them.
❖ Outline the current state of the science on the
psychosocial implications of EB on patients and their
family members.
❖ Include recommendations for care.
❖ Identify gaps in knowledge to encourage future
research.
Users These guidelines are intended for professionals
working to help those living with EB, employers,
teachers, stakeholders and policy makers. They are for
those who care for people with EB (all types) and their
families.
Target groups
❖ Professionals caring for EB patients and their
families.
❖ EB patients of all ages and diagnosed with any of the
four major types of EB: EB Simplex, Junctional EB,
Dystrophic EB and Kindler Syndrome.
❖ Families of people with EB.
Methods
The expert panel of multidisciplinary HCPs and people
living with EB was co-ordinated through Debra Inter-
national (DI) through a voluntary membership. The inter-
national panel represented clinical, social or personal
experience of EB covering both adult and paediatric
knowledge (Additional file 1. shows panel membership).
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The panel voted for their clinical representative (indicated
here as the first two authors, chair and co-chair). During
the development of the CPG two people living with EB
and four HPCs had to resign from their roles due to
changes in commitments or conflict of interest (CoI). Two
new HCPs were accepted on to the panel. Panel members
were encouraged to be involved in all stages of the CPG
development (Additional file 1).
Following the Scottish Intercollegiate Guidelines Network
[22] (SIGN) methodology, the panel decided on the re-
search question “Can psychosocial support help people to
cope with EB?” The concepts of QoL, cope and well-being
were defined to help the panel and analyses of the litera-
ture. The focus of the project was decided by considering
the relevant “PICOs” (Fig. 1): Participants were the target
populations, Interventions was to have psychosocial
support or psychotherapy or social worker support, Com-
pared to not having this support available, Outcomes and
study design. These terms were informed by: priorities
raised by people living with EB in a focus group conducted
at the Croatia DI Congress 2016; a preliminary literature
search conducted by a PhD study and presentation from an
expert in the field [23]; and further discussion about the
meaning of “psychosocial” and “cope” amongst the panel.
Literature search process
Preliminary guideline database searches were undertaken
in 2016: https://www.ahrq.gov/gam/updates/index.html;
www.g-i-n.net; www.clinicaltrials.gov and SIGN [22].
Eight guidelines in other rare conditions were identified.
There were no EB guidelines covering psychosocial care.
Fig. 1 Search terms and inclusion criteria
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A systematic literature search regime was conducted
by librarians and nine of the panel members. Twelve
electronic search engines were accessed: Medline
(PubMed MeSH), Embase Emtree PsychInfo, CINHAL,
Scopus, Dialnet, Google academic, British Nursing
Index, Health management Information consortium
(HMIC), Allied and complementary medicine (AMED),
Health business elite and the main search engine for the
National Institute for Health and Care Excellence
(NICE). Figure 1 shows the search terms, inclusion cri-
teria utilising PICOS, and the boolean AND and OR op-
erators used to combine these terms as appropriate.
Terms were kept broad, translated and searched for in
all engines (Fig. 2).
Fig. 2 Translated Key search terms
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Cited reference searches were conducted on eligible pa-
pers. Ongoing search re-runs were continued up to 1st July
2018. Every member of the panel conducted the filtration
step and research appraisal. All articles meeting the criteria
for appraisal were included (Additional file 2 copy of filtra-
tion and appraisal tool). The flowchart illustrates the inclu-
sion filters applied to all articles identified by the searches
(Fig. 3). These filters were discerned from each paper’s ab-
stract and title and, in cases of uncertainty, through KM
and SG examining the full articles. One paper in German
was filtered by a German speaking volunteer through DI.
Articles not meeting the criteria were excluded.
Book chapters, abstracts, presentations and papers
which were unpublished or did not meet the methodo-
logical filters were retained as gray literature. These were
examined to provide context or consider divergence
within the main recommendations. Four additional arti-
cles were recommended through the review process,
these were screened and 3 were excluded as they did not
meet the criteria of inclusion.
Fig. 3 Flow-chart to filter articles based on title and abstract
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Research appraisal
All published papers meeting the filters were then subject
to a systematic quality appraisal and risk of bias assessment.
The appraisal tool (Additional file 2 copy of filtration and
appraisal tool) was modified from the Critical Appraisal
Skills Programme [24] tools, GRADE [25] tools and a qual-
ity assessment framework [26]. This allowed both quantita-
tive and qualitative research to be appraised using one list
of questions, yielding one quality rating scale to allow a
comparison of studies as required. The precision and statis-
tical consistency could not be evaluated as the EB articles
had no statistical values. In most cases there was more than
50% risk of bias as it is a rare condition; there are no double
blind randomised clinical studies and most participants
would know they have EB. Study limitations were taken
into account through the appraisal tool.
Each paper was appraised by two panel members to en-
sure consistency and a research quality score was obtained;
the higher the value the better the quality of the paper. To
prevent biases and promote reliability, precautions were
taken; in cases where a panel member had authored a paper
this was reviewed by other members of the panel. The level
of bias was also measured in percentage values following
GRADE [25] (Additional file 2) and all papers were graded
in accordance to SIGN [22] method “Level of evidence and
Grades of Recommendations” 1++ to 4 and Grade A to D.
In cases of disagreement a third appraiser KM or SG was
assigned, and uncertainty resolved.
The papers were then divided into outcome topics. These
were identified through the panel ranking the outcomes’
relative importance anonymously using an online survey
(doodle.com), based on the Grading of Recommendations
Assessment Development and Evaluation [25] (GRADE).
These outcomes provided the focus of the guideline: QoL,
well-being, cope, pain (management), family (support or
counselling) and HCPs (access to service or support.
Some papers related to more than one outcome, so were
included in all that were relevant. Two or more panel
members focused on an outcome and summarised all rele-
vant papers. They presented the emerging evidence and
discussed the recommendations elicited at a meeting held
in Salzburg at EB-CLINET 2017. This summary ad-
dressed: what were the recommendations emerging from
the appraised research? What was the quality of the re-
search? Were there any gaps in this research? Did the gray
literature on this outcome support the emerging recom-
mendations or suggest something different? What was the
level of agreement of the members summarising the pa-
pers on this outcome? Outcome summary tables were
presented to highlight the population subtypes, numbers
of subjects, type of study, percentage quality and risk of
bias and in accordance to SIGN [22] method “Level of evi-
dence and Grades of Recommendations” 1++ to 4 of the
papers for each outcome.
The panel rated the strength of each recommenda-
tion, the percentage bias, desires and undesired ef-
fects, costs related to benefits and its feasibility to
implement. The GRADE [25] framework tool for rec-
ommendations was completed to standardise the
wording used to formulate recommendations for each
outcome. Summaries were circulated to the panel and
final feedback was included.
Best practice points were identified and intended to
assist guideline users by providing short pieces of advice
which are seen as essential to good clinical practice [25].
The Appraisal of Guidelines for Research & Evaluation
(AGREE) II tool [27] was consulted to increase the qual-
ity of practice guidelines in rare diseases and this CPG
acknowledges existing guidelines by signposting with the
symbol ⇒ through this manuscript.
Fig. 4 Flow of information through the evidence evaluation process
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Twenty-three expert independent referees were invited
to review the CPG, 11 signed a roles and responsibility
agreement and CoI forms prior to the anonymised
manuscript being circulated. The inclusion of experts
from the EB community reflected the multi-disciplinary
and international nature of the guideline (Additional file
1 shows author and reviewer panels). Reviewers were
asked to comment primarily on the comprehensiveness
and accuracy of the interpretation of the evidence base
supporting the recommendations, and on how this fitted
with their experiences. They were given 6 weeks to do
this. This process of review is in accordance with SIGN
[22]. The chair and co-chair discussed the reviewers’
feedback with the guideline panel: except for the two au-
thors who had originally declared a CoI. Each point was
addressed and changes made; if no change was made,
the reason for this was recorded. The panel conducted a
final proof read of the manuscript before submission.
Fig. 5 Overview evidence per outcome
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Results
A total of 34 articles were eligible for inclusion in the
final review. Figure 4 shows the flow of data through the
stages of the search, filtering and appraisal process.
These papers were then allocated to the six different out-
comes: Fig. 5 gives an overview of the selected articles after
the appraisal process and the allocation to each outcome.
QoL was the outcome with the most allocated papers (n =
15) and Access to HCPs and Pain had the least (n = 8). Fur-
thermore, Fig. 5 shows the overall number of participants,
and the number of people with different types of EB, in the
papers allocated to each outcome. It describes their meth-
odologies and the average quality of the papers per out-
come. Finally, it demonstrates the average score (and
range) on the appraisal criteria and a brief general consider-
ation, limitations and benefits per outcome.
Recommendations
The recommendations are outlined and discussed within
the context of professionals providing A. psychosocial care
for the individual with EB, B. psychosocial care for the
family and caregiver, then C. self-care for professionals
working with those affected by EB (Tables 1, 2 and 3).
Recommendation Summary Grade
strength
Quality of
evidence
(Average)
Key
references
A. Psychosocial care for individuals living with EB
We strongly recommend easy
access to psychosocial support to
improve QoL
B✓ 2++ [28–32]
We strongly recommend
psychosocial support to
improve well-being
C 2+ [32, 33–36]
We strongly recommend
gaining access to psychosocial
support for the whole family
C✓ 2- [37–39]α
We recommend psychosocial
support to help with pain
C 2- [3, 7, 17,
30, 37, 40–
44]
We strongly recommend
psychosocial support to
help coping with EB
C✓ 2- [34, 37,
45, 46]
We strongly recommend
psychosocial support from
a multidisciplinary Health Care Team
C✓ 2- [17, 29, 38,
40, 46–51]
B. Psychosocial care for family and care givers of people with EB
We strongly recommend
access to psychosocial
family support to improve
the family QoL
B 2+ [29, 30, 38]
We strongly recommend
psychosocial support to
improve family well-being
C 2- [30, 36,
50, 52–
54]
We strongly recommend
family counselling in order
to prevent family breakdown
C✓ 2- [16, 17,
30, 38, 50,
52, 55]
Recommendations (Continued)
Recommendation Summary Grade
strength
Quality of
evidence
(Average)
Key
references
We strongly recommend
psychosocial support to
help the whole family to
cope with living with EB
C 2- [16, 17,
30, 51]
We recommend
psychosocial support to
reduce emotional burden
during daily painful procedures
C 2- [35, 37,
45, 46]
We strongly recommend
easy access to a
multidisciplinary expert
team for the whole family
C 2- [17, 29,
39, 50, 51]
C. Self-care for professionals working with those affected by EB
We strongly recommend
psychosocial expertise to help
people to cope with living with EB
C 2- [17, 34, 46]
We strongly recommend
a collaborative patient-
professional relationship
C 2- [40, 49, 56]
We strongly recommend
offering support for
professionals working in EB
C 2- [40, 49, 56]
KEY: EB: Epidermolysis Bullosa; QoL: quality of life; n: number
of participants; α gray literature
Grades Descriptions in accordance to
SIGN [22]
B A body of evidence including
studies rated as 2++, directly
applicable to the target
population, and demonstrating
overall consistency of results; or
Extrapolated evidence from
studies rated as 1++ or 1+
C A body of evidence including
studies rated as 2+, directly
applicable to the target
population and demonstrating
overall consistency of results; or
Extrapolated evidence from
studies rated as 2++
Ratings Descriptions in accordance to
SIGN [22]
2++ High quality case control or
cohort studies with a very low
risk of confounding or bias and
a high probability that the
relationship is causal
2+ Well conducted case control or
cohort studies with a low risk
of confounding or bias and a
moderate probability that the
relationship is causal
2- Case control or cohort studies
with a high risk of confounding
or bias and a significant risk
✔ Recommended best practice based on the clinical experience
of the guideline development group [22]
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Table 1 Recommendations summary for the Psychosocial care of individuals living with EB
Recommendations Population Grade
strength
Quality of
evidence
(Average)
Quality of
evidence
Key
references
i. We strongly recommend easy access to psychosocial support to improve Quality of life (QoL)
A multidisciplinary approach in treating EB improves
QoL for individuals with EB
• Psychological support and close monitoring of EB
improves QoL.
• They facilitate participation in social activities.
• Patients with all types of EB including EBS report a
great impairment in QoL due to restrictions in
physical and social activities.
✓
Adults, children (n = 12/185) EBS;
JEB; DDEB; RDEB; KS
Unclear if adults, children or both
(n = 43/134) EBS; JEB; DDEB; RDEB;
Adults, children (n = 120/248) EBS;
JEB; DDEB; RDEB
Review of inherited & autoimmune
blistering diseases
B 2++ 1-
2+
2+
2-
1-
[29]
[30]
[31]
[28]
[32]
ii. We strongly recommend psychosocial
support to improve well-being
To promote self-efficacy and support around
body image to aid psychological well-being
• Having access to knowledge and resources
about EB can help people have a greater
role in managing their EB. This self-management
can help improve well-being.
• Improved self-efficacy and locus of control,
as well as support around body-image could
help to develop a more positive sense of
well-being.
For support during transition periods in life
(school transitions, transition into adulthood)
• Communication and education about EB
to improve people’s understanding.
• Support from families, EB healthcare
professionals and DEBRA.
Review of inherited &autoimmune
blistering diseases
Adults (n = 87) RDEB, DEB, EBS
Children 10–14 years old (n = 11) EBS
(autosomal recessive)
Young male adults (aged 21–35 years)
with RDEB (n = 5) and EBS (n = 2)
Observational report
C 2+ 1-
2+
2+
4
4
[32]
[33]
[34]
[35]
[36]
iii. We strongly recommend gaining access to
psychosocial support for the whole family
People diagnosed with EB should be referred
for psychosocial support as early as possible in
childhood or in adulthood, if the person with
EB wishes
• To support the family unit.
Encourage supportive network for the family,
for example:
• Education about EB for others
• Provide access to DEBRA (or other
EB support groups)
✓
Children (n = 11/82) EBS; JEB; DDEB; RDEB
Children (n = 16) JEB Adult (n = 1) RDEB
C 2- 2-
2-
4
[37]
[38]
[39]α
iv. We recommend psychosocial support to
help with pain
Pain is present for most children and adults with
EB (all types) with profound psychosocial impact:
• Activity related pain can significantly affect
psychosocial well-being and QoL (e.g. fear of/actual
pain restricting social activities, affecting
relationships with family and friends).
• Treatment related pain can make managing EB
harder and link to procedural anxiety.
Adequate holistic pain management is essential as
a focus for helping people with EB:
• Following pain guidelines.
• Offering approaches to help people with EB
cope emotionally.
• Help with managing the impact of pain and
the interlinked cycle of pain and psychosocial
challenges.
Adults, children(n = 374) EBS, JEB, DDEB,
RDEB
Adults (n = 6) JEB, DDEB
Children; (n = 11) EBS, JEB, DDEB, RDEB,
Adults (n = 30) children (n = 27) EBS
Children/families (n = 70) type of EB unclear
Adults (n = 43) EBS, JEB, DDED, RDEB
Unclear if adult/child (n = 40)
EBS, JEB, DDEB, RDEB
Best practice guideline
Children (n = 11) EBS, JEB, DDEB, RDEB
Adult (n = 1) RDEB
C 2- 2+
2-
2-
2-
2-
2+
2+
⇒
2+
3
[3]
[40]
[37]
[42]
[41]
[30]
[44]
[7]α
[17]
[43]
v. We strongly recommend psychosocial support
to help cope with living with EB
People with EB need support to cope with EB, and
their ways of coping need to be supported by
✓
Children (n = 27) DDEB; (n = 28) RDEB
C 2- 2+
2+
[45]
[34]
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Table 1 Recommendations summary for the Psychosocial care of individuals living with EB (Continued)
Recommendations Population Grade
strength
Quality of
evidence
(Average)
Quality of
evidence
Key
references
others: participation in social life needs to be
supported
• Such as at school, the community, friendships,
employment.
• Aid access to supportive networks.
• Public education campaigns to help those
around them to understand EB and their needs.
Promote a sense of self-management of their EB
• This can help bring a sense of control over
certain aspects of the disease/treatment and pain.
Build social skills and communication
• Help in learning how to communicate about
EB to others and within the family unit.
Children 10–14 years old (n = 11) EBS
(autosomal recessive)
Children (n = 11/82)
EBS; JEB; DDEB; RDEB
Children (n = 24)
EBS; JEB; DDEB; RDEB
2-
2-
[37]
[46]
vi. We strongly recommend psychosocial support
from a multidisciplinary Health Care Team
Encourage access to, and a collaborative ‘working
together’ relationship with, an expert
multi-disciplinary team of professionals.
• Facilitate access to multidisciplinary professional
support for medical and psychosocial care across
the lifespan.
• At both specialist centres and community services
✓
Adults, children (n = 15) RDEB
Children (n = 21) EBS; JEB; DDEB; RDEB
Children (n = 11/82) EBS; JEB; DDEB; RDEB
HCPs (n = 33) 30 stakeholders (HCPs, and
9 with EB RDEB, DDEB, EBS)
Adults (n = 6) JEB, DDEB
Children and Adults (n = 20) EBS, JEB, DEB
Children (n = 16) JEB
Children (n = 20) EBS, JEB, RDEB
C 2- 1-
2+
2+
2+
2-
2-
2-
2-
2-
2+
[29]
[48]
[51]
[17]
[46]
[49]
[40]
[38]
[48]
[47]
Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant
Dystrophic Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; QoL: quality of life;
n: number of; α: gray literature; ⇒this is an EB guideline
Grades Descriptions in accordance to SIGN [22]
B A body of evidence including studies
rated as 2++, directly applicable to the
target population, and demonstrating
overall consistency of results; or
Extrapolated evidence from studies
rated as 1++ or 1+
C A body of evidence including studies
rated as 2+, directly applicable to the
target population and demonstrating
overall consistency of results; or
Extrapolated evidence from studies
rated as 2++
Ratings Descriptions in accordance to SIGN [22]
1- Meta-analyses, systematic reviews, or
RCTs with a high risk of bias
2++ High quality case control or cohort
studies with a very low risk of
confounding or bias and a high
probability that the relationship is causal
2+ Well conducted case control or cohort
studies with a low risk of confounding
or bias and a moderate probability that
the relationship is causal
2- Case control or cohort studies with a
high risk of confounding or bias and a
significant risk
3 Non-analytic studies, e.g. case reports,
case series
4 Expert opinion
✔ Recommended best practice based on the clinical experience of the guideline development group [22]
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Table 2 Recommendations summary for the Psychosocial care of Family and caregivers of people living with EB
Recommendations Population Grade
strength
Quality of
evidence
(Average)
Quality of
evidence
Key
references
i. We strongly recommend access to psychosocial family support to improve the family QoL
Early psychosocial support to improve QoL of the family unit
for all subtypes EB and children with high infantile mortality:
• As caregivers QoL may also be impacted.
• Psychological support and close monitoring helps.
• Support is essential for family of palliative patients with EB.
Adults, children; 11 studies
EBS; JEB; DDEB; RDEB
Adults, children
(n = 125/185)
EBS; JEB; DDEB; RDEB; KS
Children (n = 16) JEB
B 2+ 1-
2+
2-
[29]
[30]
[38]
ii. We strongly recommend psychosocial support to improve the family well-being
Support for the family to reduce emotional burden of caring for
someone with
EB and improve well-being for the family unit:
• Home nursing can provide much needed relief and support
for primary caregivers and could reduce the need for hospital
admission.
• Actively assist in seeking counselling before the family unit
is irreparably destroyed.
• Provide information about the nature, course and outcome
of EB.
• Provide training in the management of patient symptoms.
• Access to Social media and face to face EB support groups
might be beneficial for families.
Promoting family well-being can help the family enhance their
strong and positive influence for those living with EB
• The way the family reacts to EB can be psychologically
assimilated by the person with EB, particularly children.
• Acceptance of the EB by the family is important and can
make it more bearable for the patient.
Adults, children (n = 15) RDEB
Children, Adults
(n = 374/ 425)
EBS; JEB; DDEB; RDEB
Adults, children (n = 125/185)
EBS; JEB; DDEB; RDEB; KS
Adults, children (n = 25, 14
children, 11 adults) RDEB, EBS
Adult – personal experience
C 2- 2+
2+
2-
4
2+
4
[50]
[52]
[30]
[36]
[53]
[54]
iii. We strongly recommend family counselling in order to prevent family breakdown
To help prevent the family unit breakdown, for the family of all
EB subtypes:
• Strengthen family relationships.
To prevent family emotional breakdown or distress
• Support in managing life with EB.
To prevent parents’ emotional breakdown or distress
• Specially provide support for single parents with a child
living with EB.
Children, Adults
(n = 374/ 425)
EBS; JEB; DDEB; RDEB
Adults, children
(n = 15) RDEB
Children (n = 11/82)
EBS; JEB; DDEB; RDEB
C 2- 2+
2+
2-
[52]
[50]
[17]
Adults, children (n = 28/42)
EBS; JEB; DDEB; RDEB
Children (n = 16) JEB
Children, Young Adults;
(n = 63/138) EBS; DDEB; RDEB+
2-
2-
2-
[16]
[38]
[55]
Adults, children (n = 125/185)
EBS; JEB; DDEB; RDEB; KS
2- [30]
iv. We strongly recommend psychosocial support to help the whole family to cope with living with EB
Specialist home based psychosocial support for the family of all
EB subtypes can help promote strategies to cope:
• Help access counselling to promote the intra-family
communication.
• Access help to manage EB and economic burden.
• Promote good relationships between the family
• Provide a home care program for respite, or support handing
over physical care to others.
Children (n = 21)
EBS; JEB; DDEB; RDEB
Adults, children (n = 125/185)
EBS; JEB; DDEB; RDEB; KS
Adults, children (n = 28/42)
EBS; JEB; DDEB; RDEB
Children (n = 11/82)
EBS; JEB; DDEB; RDEB
C 2- 2+
2-
2-
2-
[51]
[30]
[16]
[17]
v. We recommend psychosocial support to reduce emotional burden during daily painful procedures
Psychosocial support needs for parents and family to reduce
the emotional burden of caring for someone living with EB who
has severe pain:
• Offer psychological support for caregivers. Parents/care
givers can struggle with ‘causing pain’ due to dressing
changes and wanting to protect their child from pain.
This is very difficult emotionally for parents.
• Pain can negatively affect relationships within the family
✓
Children (n = 11/82)
EBS; JEB; DDEB; RDEB
Adults, children; (n = 57) EBS-I
Adult (n = 6/20) JEB, DDEB
C 2- 2+
2-
2-
[17]
[42]
[40]
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A. Discussion of psychosocial care for individuals
living with EB
Quality of life (Grade: B) ✓
Two observational studies investigated the impact of EB on
QoL in adults and children with all types of EB [28, 30].
They affirm that EB can have a severe impact on QoL
with the physical symptoms of EB (such as itching, pain
and stinging) having the highest impact on QoL for
adults, along with restrictions to social activities and
embarrassment due to their skin [28, 30]. Children
identified embarrassment as the highest impacting
factor, followed by physical symptoms and restrictions
to play and activities. People with EBS particularly
identified how pain restricted social activities [42].
Further work needs to be established regarding
facilitating people with EB to participate in social activities,
to enable greater QoL and well-being Although no
interventions are investigated in the research, recommen-
dations are that the provision of psychological support and
the measurement and monitoring of QoL could be benefi-
cial for people with EB [30, 32, 57] (Table 1i.).
Wellbeing (Grade: C)
People with EB can have a negative body image due to
the visibility of the condition and recognition of being
different from others [33–34]. A negative body image
can be related to poorer psychological well-being.
Women and younger people with EB may struggle more
than men in this respect [33]. For some the visibility of
EB, such as on hands and face, can invite scrutiny from
others [34, 37, 46] as can the invisibility of EB for others
[37]. The social impact of EB due to visible difference or
exclusion from activities was most strongly identified in
children’s accounts of living with EB [34].
Table 2 Recommendations summary for the Psychosocial care of Family and caregivers of people living with EB (Continued)
Recommendations Population Grade
strength
Quality of
evidence
(Average)
Quality of
evidence
Key
references
and with friends. Help optimise pain management
techniques.
• Parents/carers can find it difficult to see people in severe
pain. Aid access to respite, independent carers and promote
independence with dressings.
vi. We strongly recommend easy access to a multidisciplinary expert team for the whole family
Provide access to recognised expert support and training for
the whole family
• Provide appropriate treatment and training or refer to
national EB experts.
• Referring to with the DEBRA or EB support network may
help.
Adults, children; 11 studies
EBS; JEB; DDEB; RDEB
Adults, children (n = 15) RDEB
Children (n = 21)
EBS; JEB; DDEB; RDEB
Children (n = 11/82)
EBS; JEB; DDEB; RDEB
Adult (n = 1) RDEB
C 2- 1-
2+
2+
2+
4
[29]
[50]
[51]
[17]
[39]α
Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic
Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; QoL: quality of life; n: number of; α:
gray literature; ⇒this is an EB guideline
Grades Descriptions in accordance to SIGN [22]
B A body of evidence including studies rated as 2++, directly applicable to
the target population, and demonstrating overall consistency of results;
or Extrapolated evidence from studies rated as 1++ or 1+
C A body of evidence including studies rated as 2+, directly applicable to the
target population and demonstrating overall consistency of results; or
Extrapolated evidence from studies rated as 2++
Ratings Descriptions in accordance to SIGN [22]
1- Meta-analyses, systematic reviews, or RCTs with a high risk of bias
2+ Well conducted case control or cohort studies with a low risk of confounding
or bias and a moderate probability that the relationship is causal
2- Case control or cohort studies with a high risk of confounding or bias and a
significant risk
4- Expert opinion
✔ Recommended best practice based on the clinical experience of the guideline development group [22]
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Although there were no intervention-based studies
within the literature, the authors recommend that inter-
ventions are needed to enable people with EB to have a
stronger belief in being able to gain control over aspects
of their condition. This can be associated with
well-being and improved body image, particularly in
children with EB [33]. Having access to knowledge and
resources about EB and inviting people with EB to take
a collaborative rather than ‘being done to’ approach to
their care, can help them to have a greater role in man-
aging their EB. Specific support to help with body image
is also advocated.
Transition periods of life were identified as potentially
stressful for people with EB, impacting on their
well-being and coping. Examples of transitions include
changing classes at school and having to inform others
about EB [34]. Although there is a lack of research into
adults’ experiences, expert opinion and experienced cli-
nicians identify that transitions in adulthood can also
give rise to additional stress, such as transitioning from
school to university/college or the work place and when
developing new relationships. Children with EB and
their families can have anxieties around transitioning
from paediatric to adult healthcare settings, and regard-
ing building relationships and trust within a new health-
care environment [58]. Transition should be seen as a
process, not a single event, and partnership working be-
tween the clinical staff in both health settings, commu-
nity services and family are essential in facilitating a
smooth transition [58]. The provision of education, in-
formation and support for the individual and their fam-
ily, from EB professionals, is recommended to help
improve psychological well-being during these transition
periods [34, 36, 58] (Table 1.ii.).
Family (Grade: C) ✓
There is limited research on the interaction between the
impact of EB on the family unit and the person living
Table 3 Psychosocial management recommendations for professional working with EB
Recommendations Population Grade
strength
Quality of
evidence
(Average)
Quality of
evidence
Key
references
i. We strongly recommend psychosocial expertise to help people to cope with living with EB
Access to EB specialised care
• Nurturing a good relationship between professionals, family
and person with EB
• Training for non-EB professionals
Children 10–14 years old
(n = 11)
EBS (autosomal
recessive)
Children (n = 11/82)
EBS; JEB; DDEB; RDEB
Children (n = 24)
EBS; JEB; DDEB; RDEB
C 2- 2+
2-
2-
[34]
[17]
[46]
ii. We strongly recommend a collaborative patient-professional relationship
• Training for professionals in working collaboratively
with patients.
HCPs (N = 33) C 2- 2- [56]
iii. We strongly recommend offering support for professionals working in EB
• To promote well-being for the healthcare professional
• Emotional support is necessary: Personal support but also
on an organisational level.
• Importance of Professionals self-care: awareness, support
to do this and access to clinical supervision.
• Important to not work in isolation: the need to link in
with an MDT and to feel equipped through information
and education to help with psychosocial needs.
Key Stakeholders
(N = 30)
Key Stakeholders
(N = 30)
Adults (N = 6) JEB, DDEB
C 2- 2-
2-
2-
[56]
[49]
[40]
Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic
Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; HCPs: Health care professionals; MDT:
multidisciplinary team; n: number of; α: gray literature; ⇒this is an EB guideline
Grades Descriptions in accordance to SIGN [22]
C A body of evidence including studies rated as 2+, directly applicable to the target
population and demonstrating overall consistency of results; or Extrapolated
evidence from studies rated as 2++
Ratings Descriptions in accordance to SIGN [22]
2- Case control or cohort studies with a high risk of confounding or bias and a
significant risk
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with EB, and none looking at this into adulthood. The
impact of EB on the family unit can, however, be
profound and recommendations regarding the family’s
psychosocial needs are covered below. Based on clinical
experience and the expertise in the panel, it is likely that
the nature of EB will impact on early attachment
relationships and bonding within the family unit. The
need for psychosocial support for the person with EB as
part of a family unit is therefore advocated for all types
of EB diagnosis [37] (Table 1.iii.). People with EB can
struggle with a sense of difference compared to others in
their family, and their family life may be different to that
of other families. Empowering those around the
individual to understand EB may help. Having access to
peer relationships with other families and people living
with EB may help provide a sense of being understood,
alongside education being available to those around the
person with EB and their family; though not all
individuals or families may wish to access this resource
[38, 39]. DEBRA events and online social media support
networks could also be beneficial [35, 36].
Pain (grade: C)
The strongest conclusion to be drawn from this review
is that pain is a key theme for many people affected by
EB. The limited literature indicates that pain can have a
negative effect on children and adult’s QoL and
psychosocial well-being [59]. Most people with EB have
pain due to their skin wounds and other extracutaneous
symptoms. This can be severe and unrelenting, with as-
pects of treatment often being linked to painful proce-
dures. The pain itself can have profound effects, being
associated with frustration, embarrassment, anxiety, sad-
ness and, especially for children, fear [3, 14, 37, 40, 42].
Pain impacts on friendships and family relationships. Ac-
tivity related pain can restrict many areas associated
with positive psychosocial well-being and coping; such
as social participation, having access to peer relation-
ships, occupation, meaningful activities, and maintaining
friendships [3, 37, 40]. ⇒ It is therefore important that
support is given to manage not just the pain itself, but
also its impact psychologically and socially, and that all
possible is done to manage pain in accordance with pain
management guidelines [7].
There is much within general non-EB specific litera-
ture on psychosocial techniques for managing pain.
There are reviews regarding interventions for paediatric
pain [60, 61], other sources [62, 63] and the ⇒British
Pain Society Guidelines for pain management pro-
grammes for adults which may be helpful resources [64].
These psychosocial aspects to pain management could
be applicable to the EB population but no intervention
studies explore this generalizability. Indeed, people with
EB describe coping with pain by “blocking it out” or
distraction [40, 42] and some studies suggest a limited
use of techniques such as deep breathing and relaxation
by people with EB [40]. We recommend that pain
management is a priority within clinical management
and research aimed at improving the psychosocial
well-being of people with EB (Table 1.iv.).
Coping (Grade: C) ✓
People with EB develop individualised ways of coping
with the condition. Themes within the literature
associated with coping include having a sense of
self-management, therefore control, over aspects of their
condition and treatment; particularly for children with
EB [37]. This is echoed in the recommendation for a col-
laborative approach to healthcare outlined below.
Wherever possible support and help to participate as
fully as possible in social life needs to be advocated. This
includes at school, within the community and, as an
adult, within opportunities for employment and a role
within society. Whilst there is an ongoing struggle and
need to achieve a balance between activity and risk of
skin damage for many people with EB, access to social
participation is highlighted by both adults and children
with EB as important parts of their coping with the
condition [32, 34, 45]. Such activity also allows access to
other forms of coping such as friendships and support
networks. In childhood this socialisation and mastery of
activities is important in meeting developmental
milestones and psychosocial development.
One of the barriers to participation in activities and
social roles can be a perceived or actual lack of
understanding of others regarding the needs of people
with EB. Support and education in this regard can help,
such as public campaigns and, more specifically, support
within schools and for employers to understand how
they can assist [34]. Communication within the family
unit, alongside confidence in communicating about EB
to others is important, particularly in childhood for
building social confidence [37, 45, 46] (Table 1.v.).
Access to professional healthcare (Grade: C) ✓
Multiple studies suggest that being able to access a MDT
of professionals, providing treatment and advice on the
medical and psychosocial aspects of EB across the
lifespan, is key for improving psychosocial well-being, cop-
ing and QoL for people with EB [38, 40, 47–50]. Having a
team of people who can work collaboratively with the
person with EB and, especially in the case of children
with EB, their family and carers, can help provide a
sense of support and ease the burden of EB in every-
day life [29, 37, 50, 51]. This is also echoed in the
other recommendations around education and advice
to improving self-management of EB to aid a sense of
self-efficacy and control over the condition. Having
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professionals who are trained in recognising, under-
standing and helping with psychosocial issues is para-
mount and may also help in forming a supportive
collaborative relationship [47, 49, 56] (Table 1.vi.).
B. Discussion of psychosocial care for family and
care givers of people living with EB
Quality of life (grade: B) ✓
Life with EB has a significant impact on the entire family
and can lead to an impairment in the QoL for both the
child and parents [17, 29, 46, 52, 53, 56]. The main
determinants associated with QoL for the family of a child
with EB are [1] the severity, extent, unpredictable course
and (in) visibility of the disease [2], the pain and poor QoL
of the child [3], restrictions in employment and leisure
time [4], never being off duty and [5] ignorance and lack
of skills of care providers [17, 29, 30, 52, 51]. Findings
show early psychosocial assessment and monitoring can
improve QoL of the entire family of children with EB,
regardless of which sub-type and the expected life span
[17, 29, 30, 38] (Table 2 .i.).
Well-being (grade: C)
Many studies have identified the impact of EB on the
physical and emotional well-being of parents and caregivers.
This includes difficulties in organizing care, problems within
their own relationship, having less energy, the unpredictabil-
ity of the disease and associated difficulties with planning,
both in the short and long-term. These problems can affect
the whole family, impacting on each member’s ability to
achieve their desires and significantly lowering their level of
life satisfaction [17, 51, 65] (Table 2. ii.).
Several studies emphasise the importance of early,
extensive and long-term support for parents or care-
givers which could involve [1]: home nursing to provide
relief and help for primary caregivers and could reduce
the need for hospital admission [2], provision of infor-
mation on the nature, course and outcome of the pa-
tient’s disease [3], training of relatives in the
management of patient symptoms and in the
reinforcement of relatives’ social networks [4], and the
use of social media [30, 36, 50, 52]. (Table 2. ii.). A study
further explores how online communities could be a
particularly helpful way for people with EB to share ex-
periences and gain social support in a manageable way
across the world [64].
The reaction of family members to the condition
seems to be psychologically assimilated by their children
and can impact on them as adults living with EB. This
shows that it is important to make parents aware of how
their reaction to their child’s illness affects the
well-being of the whole family [53, 54] (Table 2. ii.).
Breakdown of the family unit (grade: C)
The potential impact of EB on the QoL and well-being of
parents with children who have EB, increases the risk of a
breakdown of the entire family unit. To prevent a family
breakdown, several studies recommended helping families
managing life with EB, strengthening family relationships
and especially supporting single parents or female carers
who may require more support [16, 17, 30, 38, 50, 52]. It
is particularly recommended that parents place import-
ance on, and pay attention to, securing their own leisure
time, holidays and social life to prevent a breakdown of
the family unit [55] (Table 2. iii.).
Access to healthcare providers and EB networks (C) ✓
Access to health professionals and EB networks is
recommended, where patients and caregivers can receive
appropriate treatment, information and training
regarding the day-to-day management of their EB, and
have the possibility to discuss personal experiences; for
example at family weekends or workshops for parents
and patients [17, 29, 39, 50, 51, 66, 67] (Table 2. vi.).
Coping (grade: C)
Parents experience great stress due to inadvertently
inflicting pain on their child when managing their daily
care. The challenge of ‘switching’ roles between being
caregiver and parent can require increased efforts to
cope, not only with physical tasks but also cognitive and
emotional challenges [17, 51, 65, 68]. Support programs
or a care manager should [1] encourage parents to
establish a normal routine for the child and family [2]
dedicate time for themselves and as a couple to help
coping [3] create a support network with the spouse,
extended family, medical staff and respite opportunities
from care [16, 17, 69] (Table 2. iv.).
Pain (Grade: C)✓
Coping with pain is interlinked with living with EB from
birth. Pain can result in negative effects on relationships
within the family [40, 42]. It is the primary concern for
caregivers who helplessly observe the wounds on the
child’s body and worry about causing pain as a
consequence of providing the care their child requires
[17, 40, 65]. Often parents separate their emotions
during painful tasks to cope [17]. Alternatively, they do
not get involved in the daily dressing routines, which
can have a positive impact on the family unit [40].
Formal expert assistances to support people living with
EB to become more independent with dressings, as well
as opportunity to access to outside carers, would
support the family unit [40] (Table 2. v.).
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C. Discussion of self-care for professionals
working with those affected by EB
It is important that people with EB have access to health
care professionals with appropriate expertise and
experience in EB (grade: C)
Access to health care professionals within the hospital
and community has been recommended, though most of
the studies in this area focus on supporting children
with EB [49] (Table 3. i). Professionals need to feel they
have adequate expertise and training to manage the
complexities of EB. There will naturally be limits to the
resources available and it is important to identify when
other services may be better placed to offer support.
Increased awareness and education is needed to equip
non-EB specialist community services to respond to the
wide range of physical and psychosocial needs of individ-
uals with EB and their caregivers. Online community
platforms could form a helpful way to disseminate EB
related factual information [64], though reliance on on-
line and telehealth platforms may need to be avoided
when physical medical examination by specialists forms
a crucial part of EB medical care.
Health care professionals need to aim for collaborative
patient-professional relationships
Studies have also made recommendations regarding the
process of supporting adults with EB [14, 38, 40, 70].
Physicians need to acknowledge “the active role of the
patients as an informed, involved and interactive partner
in the treatment process” [70]. Professionals providing
medical intervention need to support patients to develop
confidence and motivation to use their own skills and
knowledge, enabling them to take effective control over
managing their condition. Adults with EB often view
themselves as “experts yet also valuing the expertise of
others” [40]. EB care needs to be viewed as “a
partnership” between individuals with EB and healthcare
professionals. Striking a balance between maintaining
and valuing self-efficacy in managing EB, whilst promot-
ing access to support and specialist intervention, is very
important. Professionals providing these services would
benefit from training in working with people with rare
conditions. In particular, the process of supporting as-
sertive and well informed patients, as well as patients
who decline or struggle to engage with healthcare ser-
vices (Table 3. ii).
Healthcare professionals working with people with EB
should work in experienced teams providing support for
themselves (Grade: C)
Clinicians working in the area also benefit from access
to professional support [32]. EB professionals often work
in isolation and this is not good for their own
psychological health. Access to clinical supervision, skills
training in recognising psychosocial difficulties and
access to multidisciplinary team support are important
considerations. This is an important recommendation to
consider the deep emotional impact that HPCs can
encounter when working in EB care [71]. A range of
professional are involved in EB care at specialist
hospital, community and voluntary settings; it is
important that all involved have access to shared
support and supervision. Issues around professional
limitations, difficulties and boundaries need to be
acknowledged and discussed openly rather than
managed in isolation (Table 3. iii).
Conclusions
These guidelines provide evidence-based recommenda-
tions to optimise the care for people living with EB and
their families. EB is a disease that impacts on many dif-
ferent aspects of life. Besides the extensive medical as-
pects, psychosocial well-being is also highly affected.
Many factors influence psychosocial well-being and cre-
ate a complex interaction between disease-specific fea-
tures, individual characteristics, environmental issues
and socio-economic circumstances.
Starting from an evidence-driven approach, these
guidelines form a framework with recommendations that
can be used by people living with EB, their families and
caregivers and professionals. After a comprehensive sys-
tematic literature search, the main conclusion we can
make is that evidence from interventional studies is lim-
ited. Most existing research is explorative in focus, aim-
ing to investigate the impact of EB, rather than
interventions which help. Therefore, these guidelines
provide general recommendations that can be used as a
basis to start an individual-focused approach for sup-
porting people with EB and their families, and to inform
future research.
There is a good understanding of which parts of life
are difficult for people with EB. The management of
pain is a key part of psychosocial well-being, impacting
on QoL and coping with EB [40]. Physical discomfort
(pain, itching, wound care etc.) plays an important role
in the limitations people with EB and their family are ex-
periencing. To cope with this discomfort is a daily mis-
sion, demanding a great amount of effort and energy.
Whilst there is a⇒CPG specifically on pain in EB [7]
this CPG utilised only research specifically on pain and
psychosocial aspects for people with EB; the Pain spe-
cific CPG included non-EB specific papers. There is a
lack of intervention studies exploring the application
and efficacy of psychosocial techniques for managing
pain in EB. Techniques such as pacing and planning ac-
tivities, relaxation, distraction, managing anxiety, tension
and cognitive attributions may all be helpful but there is
no clear evidence allowing this formal recommendation.
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It seems that living with EB is more bearable when
people with EB feel supported and integrated in society.
Participation in social life, peer support and a sense of
self-realisation are key constructs needed for people with
EB to optimise their social well-being and to cope with
the difficult effects of EB. In our expert opinion and syn-
thesis of the existing, though limited, evidence base,
multidisciplinary professionals, and those supporting
and caring for people with EB, should use their expertise
to help people living with EB and their families to realise
these constructs. People with EB and their caregivers
will become the experts in their own situation. A strong
collaboration between the scientific driven expertise of
professionals and the experience driven expertise of
people with EB and their surroundings is recommended.
Starting from infancy, children with EB need to be
encouraged to follow their psychosocial developmental
milestones, alongside meeting their physical needs. More
concretely, this could mean that in early childhood a
supportive team should focus on pain management so
there can be a secure attachment between children, their
parents and the surrounding world. When they are
older, they should be able to discover the world, being
supported to have a certain grade of mobility and
independence: psychologically, socially and where
possible physically. As children grow into adulthood,
there are a lot of obstacles disturbing their process of
psychosocial development and management of EB.
Examples of those possible obstacles are: gaining
independency, pain as a strong conditioner to
developing anticipatory anxiety and general anxiety,
absence from school and peer relationships, physical
limitations influencing the ability to participate in social
activities, difficulties with poor body image, challenging
transition periods and identity development. Young
adults with EB could wrestle with difficult themes such
as sexuality, intimacy, relationships and the sense of
reaching their potential in life (self-realisation). Also, for
adults with EB, it is not easy to find their way and place
in society, but having a sense of belonging, a role,
routine and meaningful activity all help with their
psychosocial well-being.
The interaction of physical limitations and discomfort
caused by EB, with these aforementioned psychosocial
developmental tasks that every child and adult have to
go through, is complex. There is a scarcity of research
about which interventions in childhood give the best
outcomes in adulthood, not only in EB, but also in other
chronic and invasive diseases. There is also limited
research into how adults living with EB and their
families can overcome and manage the psychosocial
challenges of EB. Most of the recommendations made in
this paper are therefore not concrete and a golden
standard of care could not be created.
A supportive network seems invaluable. The biggest
recommendation we can make to optimise psychosocial
well-being of those with EB and their families, is to fa-
cilitate participation in society and peer support. Every
person has to find his role in life and society and the
search for this can be really difficult for those living with
EB. These challenges could also extend to family mem-
bers caring for someone with EB where parents may
have to adapt/change family roles to meet the care needs
of a child with EB. This can have social and economic
implications for the whole family and affect each mem-
ber’s ability to achieve their own desires.
Parents can experience immense psychological stress
due to inflicting pain on their child while managing their
daily care. The challenge of being both the parent who
wants to protect their child and the caregiver who has
to, at times, impose pain due to the child’s physical and
medical needs can take a toll on parent’s well-being.
Therefore, it is very important to provide early, extensive
and long-term support for family members to enable
them to cope with the emotional burden that they carry
as care providers and regarding their option to bring in
outside caregivers or respite. Psychosocial support is rec-
ommended to assist families to manage life with EB.
Supporting families can help to strengthen family rela-
tionships, prevent family breakdown and improve family
members QoL and well-being. The literature suggests a
link between family members’ reaction to EB, which is
assimilated by the child, impacting later on into adult-
hood. Therefore, if family members are supported, this
can also have psychological benefits for the individual
living with EB.
There can be a lack of knowledge and understanding
about EB in schools, working places, leisure time groups
or in peer relationships. Moreover, many social activities
or public places are not sufficiently adapted for the
needs of people with EB; like supermarkets, shops,
restaurants, hotels, transportation. A focus on raising
awareness of EB in general and on the psychosocial
needs of people with EB is essential. Providing
information and training about EB for family members
is also recommended to enable them to have a deeper
personal understanding about the condition and disease
process. Providing family members with information
also can equip them to feel more confident in managing
situations where EB is not understood. The role of the
HCP is important in assisting family members and
carers in their understanding of EB and providing them
with social support.
Health care professionals can play a supportive role in
all of the aforementioned aspects of life and
development. They should use their expertise to provide
an individualised approach for every person with EB.
This can be a demanding task and there are limits to
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resources available; being aware of the limits and
boundaries to their professional responsibilities and
capabilities is important. The complexity of this disease
is also felt by health care professionals. Feelings of
powerlessness and not being able to help enough can be
overwhelming, especially given the potentially long-term
relationship between professionals and persons living
with EB and their family. Therefore, it is essential that
health care professionals adopt self-care awareness. They
have to take care of themselves in order to be able to
care for others. Clinical supervision, having space to re-
flect and process their experiences of caring and being
able to rely on colleagues in a MDT appears necessary.
Otherwise the burden of EB can also be hard to carry
for health care professionals.
Limitations of the guideline
The authors acknowledge limitations with this CPG.
The panel is formed from international volunteers
from the EB community. They are experts in EB but
not on CPG methodology. The contribution of a
methodology expert to the panel has, however, sought
to ensure a high quality robust methodology process.
As EB is a rare condition there is a limited numbers
of volunteering experts, also people living with EB
can be very unwell very quickly, and professional’s
clinical responsibilities take priority. This can all add
some limitations and challenges but despite this all
panel members were encouraged to participate in all
stages of developing these recommendations; to
promote ecological validity and ensure an inclusive
approach.
The CPG focuses only on summarising the published
papers and gray literature identified by the search
process. This is presented within the context of the
primary six outcomes and utilises only EB specific
papers. There may well be an overlap regarding the
psychosocial difficulties experienced by people with EB
and their families, and other conditions or groups of
people: such as, for example, people with other physical
differences, rare diseases or life-long, painful or and fluc-
tuating conditions. A next step may be to look at the lit-
erature in these areas to see if it can be generalised to
EB populations. The EB community, in terms of people
with EB, their families and professionals, is a small one.
The individuals forming the review panel all chose to
not be anonymous with their feedback. Whilst the au-
thors’ names were hidden from the review panel, it is
likely that some may have known the people writing this
review. The implication for the peer review process is
unknown. This may be taken as a strength, allowing the
writing panel to follow up any comments and points
made directly, but it may be a limitation in that the
Fig. 6 Areas of research for the individual, family, caregivers
and professionals
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review panel may not be seen as wholly ‘independent’
from the authors. With funding for clinical care being
limited, with a keen focus on funding for research into
physical care, the authors acknowledge that the review
panel may carry their own biases regarding their inter-
pretation of the guidelines, their support for its publica-
tion, or may be competitors with biases towards the
centres involved in this guideline.
Future research
This guideline highlights the need for further high-quality
research, to understand how best to support and manage
the psychosocial needs and coping of people living with
EB and their families. Present research goes some way to-
wards understanding the nature of the psychosocial chal-
lenges presented by EB, but little is known about how to
actually address or manage these effectively. Whilst there
is evidence supporting psychosocial interventions for a
range of difficulties commonly experienced by people with
EB, in areas such as pain management, anxiety and social
interactions, there is limited research investigating the ap-
plication of these to an EB population. There is a lack of
focus on adulthood as opposed to managing EB in child-
hood, and EBS is also under-represented. Two areas of re-
search paucity therefore include studies evidencing
interventional approaches and on the management of psy-
chosocial difficulties into adulthood. The rarity of EB may
lead to difficulties with small and heterogeneous samples,
making quantitative studies complex: international collab-
orations may be explored as an option to help.
The research questions and areas have emerged as
requiring further investigation (Fig. 6):
Implementation of guideline recommendations and
update
DEBRA International aims to ensure that the EB
guidelines address the needs of patients internationally.
These guidelines will be translated into other languages
and patient versions will be made to aid accessibility.
These guidelines could be disseminated and promoted
through education for professionals and considering how
they could be incorporated into clinical practice. The
guidelines were presented at the International DEBRA
Congress 2018. The implementation and impact of these
recommendations could be monitored and evaluated
through audits, education programme registration, and
the CPG Evaluation Form: Pre implementation
(Additional file 3). The panel recommends sites to
pre-audit practice, implement the CPG and re-audit to
test improvement, audits tools can be used from SIGN.
DEBRA International would value your feedback on the
findings to continue to improve CPG quality.
The guidelines should be updated every 3–5 years or if
there is a significant breakthrough in EB psychosocial care
from the publication date. We recommend a re-run of
search terms to see if a full review is warranted at this point.
Additional files
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